Basic Information
| LncRNA/CircRNA Name | LINC00973 |
| Synonyms | NA |
| Region | GRCh38_3:98981058-98983096 |
| Ensemble | ENSG00000240476 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | RNA-seq, qPCR etc. |
| Sample | cell line (HCT-116 and HT-29) |
| Expression Pattern | up-regulated |
| Function Description | The most frequent changes were detected for LINC00973, whose content is most strongly and consistently increased upon treatment of both colon cancer cell lines with all three chemotherapeutic drugs. |
| Pubmed ID | 29870803 |
| Year | 2018 |
| Title | Expression of long non-coding RNA LINC00973 is consistently increased upon treatment of colon cancer cells with different chemotherapeutic drugs. |
External Links
| Links for LINC00973 | GenBank HGNC NONCODE |
| Links for colon cancer | OMIM COSMIC |